Literature DB >> 15781223

Collagen overglycosylation: a biochemical feature that may contribute to bone quality.

Ligia J Dominguez1, Mario Barbagallo, Luigi Moro.   

Abstract

Skeletal ability to resist mechanical stress is determined by bone amount and quality, which relies on macro- and micro-architecture, turnover, bone matrix, and mineralisation; the role of collagen has not been clearly elucidated. Numerous post-translational steps are involved in collagen type I biosynthesis, including residue hydroxylation and glycosylation catalysed by enzymes that work until the protein folds forming the triple helix; therefore, folding rate regulates these processes. Overglycosylated hydroxylysines are poor substrates for epsilon-amino group deamination which initiates cross-link formation. Three clinical conditions associated with fractures may relate collagen overglycosylation with bone quality: (i) Osteogenesis Imperfecta, in which genetic mutations distort triple helix conformation and slow folding rate favouring overglycosylation; (ii) diabetes mellitus, with collagen overglycosylation by AGE accumulation; and, (iii) menopause, according to experimental studies demonstrating ovariectomy-related trabecular bone collagen overglycosylation preventable by 17beta-estradiol or tamoxifen. Specific actions on collagen of drugs used for bone protection should be explored in future studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781223     DOI: 10.1016/j.bbrc.2005.02.050

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  The role of collagen in bone strength.

Authors:  S Viguet-Carrin; P Garnero; P D Delmas
Journal:  Osteoporos Int       Date:  2005-12-09       Impact factor: 4.507

2.  Surface-sensitive Raman spectroscopy of collagen I fibrils.

Authors:  Corinne Gullekson; Leanne Lucas; Kevin Hewitt; Laurent Kreplak
Journal:  Biophys J       Date:  2011-04-06       Impact factor: 4.033

3.  Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast culture.

Authors:  Marnisa Sricholpech; Irina Perdivara; Hideaki Nagaoka; Megumi Yokoyama; Kenneth B Tomer; Mitsuo Yamauchi
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

4.  The post-translational phenotype of collagen synthesized by SAOS-2 osteosarcoma cells.

Authors:  Russell J Fernandes; Michael A Harkey; Maryann Weis; Jennifer W Askew; David R Eyre
Journal:  Bone       Date:  2007-01-25       Impact factor: 4.398

5.  Anulus fibrosus tension inhibits degenerative structural changes in lamellar collagen.

Authors:  Jeffrey C Lotz; Tamer Hadi; Clayton Bratton; Karen M Reiser; Adam H Hsieh
Journal:  Eur Spine J       Date:  2008-07-31       Impact factor: 3.134

6.  Muscle weakness as presenting symptom of osteogenesis imperfecta.

Authors:  Annemieke M Boot; Rene F M de Coo; Gerard Pals; Sabine M P F de Muinck Keizer-Schrama
Journal:  Eur J Pediatr       Date:  2006-03-14       Impact factor: 3.183

7.  Comprehensive Characterization of Glycosylation and Hydroxylation of Basement Membrane Collagen IV by High-Resolution Mass Spectrometry.

Authors:  Trayambak Basak; Lorenzo Vega-Montoto; Lisa J Zimmerman; David L Tabb; Billy G Hudson; Roberto M Vanacore
Journal:  J Proteome Res       Date:  2015-12-09       Impact factor: 4.466

Review 8.  Clinical perspectives on bone quality in osteoporosis: effects of drug therapy.

Authors:  Angelo A Licata
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  Impaired pyridinoline cross-link formation in patients with osteogenesis imperfecta.

Authors:  Kosei Hasegawa; Kyoko Kataoka; Masaru Inoue; Yoshiki Seino; Tsuneo Morishima; Hiroyuki Tanaka
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

10.  Unusual fragmentation pathways in collagen glycopeptides.

Authors:  Irina Perdivara; Lalith Perera; Marnisa Sricholpech; Masahiko Terajima; Nancy Pleshko; Mitsuo Yamauchi; Kenneth B Tomer
Journal:  J Am Soc Mass Spectrom       Date:  2013-04-30       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.